Mirae Asset Global ETFs Holdings
NGNE icon

Mirae Asset Global ETFs Holdings’s Neurogene NGNE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
5,307
+716
+16% +$13.9K ﹤0.01% 2637
2025
Q4 		$94.6K Sell
4,591
-34
-0.7% -$846 ﹤0.01% 2703
2025
Q3 		$80.2K Sell
4,625
-759
-14% -$15.2K ﹤0.01% 2765
2025
Q2 		$80.5K Sell
5,384
-1,599
-23% -$25.1K ﹤0.01% 2713
2025
Q1 		$81.8K Buy
6,983
+1,059
+18% +$18.4K ﹤0.01% 2720
2024
Q4 		$135K Buy
5,924
+228
+4% +$8.48K ﹤0.01% 2577
2024
Q3 		$239K Buy
+5,696
New +$221K ﹤0.01% 2286

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NGNE Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Neurogene (NGNE) stake by 16% in Q1 2026, buying an estimated $13.9K and bringing the position to 5,307 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Mirae Asset Global ETFs Holdings first reported a position in NGNE in Q3 2024 and has held it in 7 quarters since. The position peaked at $239K in Q3 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 5,307 shares of Neurogene worth $107K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 716 Neurogene shares in Q1 2026, an estimated $13.9K.
  • Neurogene made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2637 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Neurogene in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Neurogene position peaked at $239K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.